期刊文献+

影响慢性心力衰竭患者心脏再同步化治疗效果的因素分析 被引量:8

Factors associated with the efficacy of cardiac resynchronization therapy in patients with chronic heart failure
原文传递
导出
摘要 目的 观察慢性心力衰竭患者心脏再同步化治疗(cardiac resynchronization therapy,CRT)的临床疗效,比较CRT有反应和无反应患者的临床特征,分析不同因素对CRT反应及预后的影响.方法 选取在浙江大学医学院附属第二医院心血管内科成功置入CRT-P/D的慢性心力衰竭患者204例,收集术前临床资料、手术资料及术后随访资料,结合手术前后临床症状及超声心动图参数的改善,评估CRT疗效.比较有反应和无反应患者的临床特征,并通过多因素回归分析及生存分析比较不同因素对CRT反应及预后的影响.结果 纳入研究者共204例,其中男性130例,女性74例,平均年龄(64.8±11.9)岁,随访6~60个月.CRT有反应者125例(61.3%).有反应的患者中,女性、QRS波时限≥150 ms及QRS波形态呈完全性左束支传导阻滞(CLBBB)者所占比例分别为41.6% (52/125)、58.4%(73/125)、65.6%(82/125),明显高于CRT无反应的患者(P<0.05).多因素回归分析显示,QRS波时限≥150 ms是CRT有反应的唯一独立预测因子.Kaplan-Meier法分析显示CRT有反应的患者生存率高于无反应的患者(P<0.001).结论 临床特征,包括女性、QRS波时限≥150 ms及CLBBB,与CRT反应密切相关,其中QRS波时限≥150 ms能独立预测CRT有反应.CRT有反应的患者预后优于无反应的患者. Objective To observe the clinical effects of cardiac resynchronization therapy (CRT)in patients with chronic heart failure,and compare the clinical characteristics and outcome between responders and non-responders to define factors related to the efficacy of CRT.Methods We retrospectively analyzed the data of patients underwent CRT-P/D implantation from January 2006 to December 2012 in our Hospital.All patients received long-term follow-up including NYHA classification,left ventricular ejection fraction (LVEF) and left ventricular internal dimension at end diastole (LVIDd).Results A total of 204 patients were included (130 males,mean age (64.8 ± 11.9) years).The total response rate of CRT was 61.3%.Women,QRS duration ≥150 ms,and left bundle branch block (LBBB) were related with better response after CRT (all P 〈 0.05).Multivariate regression analysis showed that QRS duration was an independent determinant for CRT response.All-cause mortality rate was significantly lower in responder group than in non-responder group (P 〈 0.001).Conclusions In patients with chronic heart failure,women,QRS duration ≥ 150 ms,and LBBB are related with better CRT response rate post CRT.QRS duration ≥ 150 ms is an independent predictor of CRT response,and positive response is associated with lower all-cause mortality in this oatient cohort.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2014年第9期731-735,共5页 Chinese Journal of Cardiology
关键词 心力衰竭 充血性 治疗结果 心脏再同步化治疗 Heart failure,congestive Treatment outcome Cardiac resynchronization therapy
  • 相关文献

参考文献16

  • 1Abraham WT,Fisher WG,Smith AL,et al.Cardiac resynchronization in chronic heart failure[J].N Engl J Med,2002,346:1845-1853.
  • 2Cuoco FA,Gold MR.Optimization of cardiac resynchronization therapy:importance of programmed parameters[J].J Cardiovasc Electrophysiol,2012,23:110-118.
  • 3Ypenburg C,van Bommel RJ,Delgado V,et al.Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy[J].J Am Coll Cardiol,2008,52:1402-1409.
  • 4van Bommel R J,Bax JJ,Abraham WT,et al.Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy:a PROSPECT (Predictors of Response to CRT) sub-analysis[J].Eur Heart J,2009,30:2470-2477.
  • 5Singh JP,Klein HU,Huang DT,et al.Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial[J].Circulation,2011,123:1159-1166.
  • 6Wells G,Parkash R,Healey JS,et al.Cardiac resynchronization therapy:a meta-analysis of randomized controlled trials[J].CMAJ,2011,183:421-429.
  • 7Dickstein K,Cohen-Solal A,Filippatos G,et al.ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008:the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)[J].Eur J Heart Fail,2008,10:933-989.
  • 8Stavrakis S,Lazzara R,Thadani U.The benefit of cardiac resynchronization therapy and QRS duration:a meta-analysis[J].J Cardiovasc Electrophysiol,2012,23:163-168.
  • 9Dickstein K,Vardas PE,Auricchio A,et al.2010 Focused Update of ESC Guidelines on device therapy in heart failure:an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy.Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association[J].Europace,2010,12:1526-1536.
  • 10Zar(e)ba W.Comparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart failure[J].Cardiol J,2010,17:543-548.

共引文献51

同被引文献63

  • 1Tang AS, Wells GA, Talajic M, et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure [ J ]. N Engl J Med, 2010, 363 (25) :2385-2395. DOI : 10. 1056/NEJMoa1009540.
  • 2Masoudi FA, Mi X, Curtis LH, et al. Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study [ J ]. Ann Intern Med, 2014, 160 ( 9 ) : 603-611. DOI : 10. 7326/M13-1879.
  • 3Packer M. Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failure [ J ]. Circulation, 1990, 81 (2 Suppl) : III78-III86.
  • 4Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone [ J 1. J Am Coll Cardiol, 1997, 30 ( 1 ) :8-18.
  • 5Yu CM, Zhang Q, Yip GW, et al. Are left ventricular diastolic function and diastolic asynchrony important determinants of response to cardiac resynchronization therapy [ J 1. Am J Cardiol, 2006, 98 ( 8 ) : 1083-1087. DOI : 10. 1016/j. amjcard. 2006.05. 028.
  • 6Waggoner AD, De Las Fuentes L, Faddis MN, et al. Left ventricular diastolic filling prior to cardiac resynchronization therapy : implications for atrioventricular delay programming [ J ]. Pacing Clin Electrophysiol, 2008, 31 (7):838-844. DOI: 10. 1111/j. 1540-8159. 2008. 01097. x.
  • 7Risum N, Sogaard P, Hansen TF, et al. Comparison of dyssynchrony parameters for VV-optimization in CRT patients [ J ]. Pacing Clin Electrophysiol, 2013, 36 ( 11 ) : 1382-1390. DOI: 10. 1111/pace. 12203.
  • 8Chung ES, Leon AR, Tavazzi L, et al. Results of the Predictors of Response to CRT (PROSPECT) trial[ J 1. Circulation, 2008, 117(20):2608-2616. DOI: 10. ll61/CIRCULATIONAHA. 107. 743120.
  • 9Lehner S, Uebleis C, SehOl31er F, et al. The amount of viable and dyssynehronous myocardium is associated with response to cardiac resynchronization therapy: initial clinical results using multiparametric ECG-gated [ 18F] FDG PET[ J]. Eur J Nucl Med Mol Imaging, 2013, 40(12) :1876-1883. DOI:10. 1007/s00259- 013-2516-6.
  • 10Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis[ J]. J Am Coll Cardiol, 2004, 43 ( 3 ) :317-327. DOI : 10. 1016/j. jacc. 2003.07. 046.

引证文献8

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部